Aranesp Oncology Costs: “Exorbitant” (J&J); “Very Competitive” (Amgen)

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet